News - Burrill

Video

View G. Steven Burrill's Presentation from BioConference Live
November 17, 2009.

View video

Podcast

Eric Topol, chief medical officer of the West Wireless Health Institute, discusses consumer digital healthcare and how the convergence of technologies is empowering patients, attacking the high cost of chronic diseases, and making the long-sought promise of personalized medicine a reality.

Hear the podcast

G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

G. Steven Burrill

News

Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release

Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release

Biotech Closes the Year on an Upswing January 04, 2010 | Press Release

Sign up for a free subscription to The Burrill Weekly Brief

All News

Biotech posts gain in February as broader markets strengthen

March 03, 2010

Biotech holds steady in January as broader markets head south

February 01, 2010

Biotech Closes the Year on an Upswing

January 04, 2010

Biotech gets back on track in November

December 01, 2009

Biotech takes it on the chin in October

November 02, 2009

Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions

Joint venture will focus on select healthcare companies

October 09, 2009

Biotech gets on a roll in third quarter

October 01, 2009

FDA Commissioner Dr. Margaret Hamburg headlines at the Burrill Annual Personalized Medicine Meeting

September 16, 2009

Biotech cools off in August but capital markets remain positive

September 01, 2009

Biotech hot in July driven by positive drug data and acquisitions

August 03, 2009

NewBridge Pharmaceuticals Announces Licensing of Pylera® for Middle East, Africa, Turkey & Caspian Region

July 22, 2009

Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment

July 16, 2009

Burrill & Company invests in Taiwan Liposome Company

July 07, 2009

Biotech buoyed by strong capital market performance in second quarter

July 01, 2009

Shawn Cross Joins Burrill Merchant Banking

June 16, 2009

Biotech shows glimmer of an upward trend

June 01, 2009

Biotech drops on weaker first quarter drug sales, but broader markets remain on a roll

May 01, 2009

Burrill & Company announces promotions

April 10, 2009

Biotech finishes down after turbulent quarter

April 01, 2009

Burrill Merchant Banking Advises Adlyfe on Alzheimer’s Biomarker Partnership with Wyeth

March 17, 2009

Elk Run Developers Announce Partnership With Leading Life Sciences Firm

March 12, 2009

R&D Spending by U.S. Biopharmaceutical Companies increases 3 percent in 2008

March 10, 2009

Biotech takes a hit following the Administration’s budget plans for healthcare

March 02, 2009

Biotech Industry Turns a Profit for the First Time, But Milestone Overshadowed as Companies Struggle for Survival, Report Finds

February 25, 2009

Biotech holds steady as broader markets tumble

February 02, 2009

Biotech holds up well in the face of financial crisis and market turmoil

January 02, 2009

G. Steven Burrill predicts what’s ahead for biotech in 2009

January 02, 2009

Biotech’s small cap companies restructuring to conserve cash

December 01, 2008

Biotechs claw for their lifeblood - financing

November 17, 2008

Biotech Visionary, G. Steven Burrill receives DiNA

November 14, 2008

Redpoint Bio Retains Burrill & Co. to Advise on Strategic Alternatives

November 12, 2008

Biotech reels from one of the worst months on record for the capital markets

November 03, 2008

Victor A. Hebert joins Burrill & Company

October 10, 2008

Biotech takes a beating in market meltdown

October 01, 2008

Burrill Merchant Banking advises Mitsubishi Tanabe Pharma Corporation on transactions with Cytochroma Inc.

September 08, 2008

Biotech drops back to earth in August

September 03, 2008

Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber

August 01, 2008

Biotech remains upbeat in wake of market turmoil

July 01, 2008

Genetic test industry faces tough challenges with consumers, survey finds

June 17, 2008

G. Steven Burrill Presents the 'State-of-the-Industry' at BIO 2008

June 17, 2008

Biotech outperforms market in May

June 02, 2008

Biotech Treads Water in April

May 01, 2008

Burrill Opens Registration for its 3rd Annual India Life Sciences Meeting

April 25, 2008

Burrill Opens Registration for its 4th annual Burrill China Life Sciences Meeting

April 25, 2008

Personalized medicine is having a dramatic effect on healthcare delivery

April 21, 2008

Seventh Annual Aged To Perfection Gala To Attract Wine Lovers of San Francisco

April 16, 2008

Biotech 2008 Teleconference with G. Steven Burrill

April 15, 2008

Biotech avoids fall out from tough quarter for capital markets

April 01, 2008

Biotech drops amid tough markets in February

March 03, 2008

January market jitters fails to derail biotech

February 01, 2008

Biotech has positive year despite weak fourth quarter performance

January 02, 2008

Biotech Hit by Market Jitters in July

August 01, 2007

Biotech Remained Flat in May

June 06, 2007

Biotech Establishes New Record for Market Cap in April

May 01, 2007

Dr. Ganesh M. Kishore joins Burrill & Company

April 20, 2007

Burrill Merchant Banking Advises QLT USA on divestment of QLT USA, INC.'s Generic Dermatology and Manufacturing Business

April 12, 2007

Stem Cell Summit Launched

March 23, 2007

Biopharmaceutical Industry Research & Development Tops $55 Billion In 2006

February 12, 2007

Randy Guggenheimer Joins Burrill Merchant Banking

January 04, 2007

Anton Gueth Joins Burrill Merchant Banking

December 06, 2006

Burrill Merchant Banking Advises FAES Farma on Phase III Licensing Agreement

November 29, 2006

Burrill Merchant Banking Newsletter Q3, 2006

November 10, 2006

Mohan S. Iyer Joins Burrill & Company's Merchant Banking Group

April 24, 2006

A Changing Prescription for Biotechnology

April 11, 2006

Burrill & Company and Beijing Pharmaceutical Group Form Strategic Partnership to Capture Cross-Pacific Life Sciences Opportunities

April 11, 2006

Biopharmaceutical Industry Research & Development Tops $51 Billion In 2005

March 07, 2006

Biotech’s Mid Caps Post Solid Gain in February

March 03, 2006

Burrill's Biotech Outlook For 2006 ...and A Look Back At 2005

December 23, 2005

Burrill & Company Advises Danisco A/S on Divestiture of Genencor Oncology Program

November 09, 2005

Midwest Will Be Next Biotech Hotbed

September 28, 2005

Hal Gerber, M.D Joins Burrill & Company’s Merchant Banking Group To Further Expand M&A Services

August 01, 2005

Burrill & Company launches China Access Forums to provide gateway for North America Life Sciences companies to access China opportunities

March 24, 2005

Biopharmaceutical Industry Research & Development Tops $49 Billion In 2004

March 17, 2005

Jonathan Wang Joins Burrill & Company to Focus on Greater China Opportunities

February 02, 2005

Burrill & Company Announces the Life Sciences Capital Fund III

January 07, 2005

Biotech Recognized as One of San Francisco Mayor Gavin Newsom's First Year Accomplishments

January 07, 2005

Burrill & Company's Merchant Banking Practice Announces Increasing Spin-Out Activity From Pharmaceutical Companies

January 07, 2005

Burrill & Company Announces Promotions and Organizational Changes to Reflect the Growth of its Business

January 05, 2005

Burrill's Biotech Outlook for 2005

December 22, 2004

Biotech Honors The Best of 2004

October 14, 2004

20,000 Biotech Executives Gather at Bio in San Francisco Biotech on Track for Success

June 08, 2004

Burrill & Company Announces Closing of Burrill Life Sciences Capital Fund

January 12, 2004

Mitsubishi Corporation Invests in Burrill Life Sciences Capital Fund

September 17, 2003

Biotech is Back

June 24, 2003

A Year of Revaluation and Restructuring for Biotech

May 09, 2003

Biotech Endures Looking Back at 2002 and Ahead to 2003…

December 12, 2002

James Watson Joins Burrill & Company to Focus on its Strategic Partnering Services

November 25, 2002

G. Steven Burrill is Recognized as Biotech Investment Visionary by Scientific American

November 20, 2002

Novel Alliance to Promote Biotech Strategic Partnerships with Israeli Companies

October 07, 2002

Burrill & Company and Biostreet Join Forces

January 02, 2002

Biotech Recognizes the Year's Best

October 11, 2001

News Archive: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | View All